Drug Discovery company. Developing novel molecules for the treatment of obesity.
| Website | https://eolo-pharma.com/ |
| Revenue | $2 million |
| Employees | 17 (5 on RocketReach) |
| Founded | 2017 |
| Address | Sutter St, San Francisco, California, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Drug Discovery, Retail, Pharmaceuticals |
| Competitors | Ipsen, Galderma, Revance, Evolus, Actavis plc (now Allergan), Sientra, Inc., Medytox, Hugel Inc. +28 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular EOLO PHARMA employee's phone or email?
The EOLO PHARMA annual revenue was $2 million in 2026.
María Garat is the CEO of EOLO PHARMA.
5 people are employed at EOLO PHARMA.
EOLO PHARMA is based in San Francisco, California.
The NAICS codes for EOLO PHARMA are [325, 3254, 32, 32541].
The SIC codes for EOLO PHARMA are [28, 283].